Offering the best quotes for your research!

New and used scientific instruments

🚚 Shipping Worldwide 🌎

✉️ info@questpair.com

Back to all brands

Filters

For Sale

For Rent

Do you have items to sell? Post them on QuestPair and reach thousands of potential buyers!

Post New Item

Illumina: Pioneering Genomics

Introduction

Illumina, Inc., established in 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee, quickly rose to prominence in the field of genomics. Originating as a start-up from San Diego, California, the company has undergone significant growth, including the acquisition of Solexa in 2007, which allowed it to expand its sequencing capabilities. Today, Illumina stands as a globa

(more)l leader in DNA sequencing and array-based technologies, serving customers in research, clinical, and applied markets. #### Core Product Offerings Illumina's main product lines include sequencing and microarray technologies that cater to the needs of genomics research. The company is particularly renowned for its next-generation sequencing (NGS) platforms, such as the NovaSeq, HiSeq, MiSeq, and the benchtop iSeq 100 systems. These platforms have revolutionised the speed, cost, and accuracy of sequencing, making it accessible to a wider range of research and clinical applications. In addition to hardware, Illumina offers a suite of software for data analysis and management, as well as reagents and consumables that complement their instruments. #### Industries Served Illumina's technologies are integral to a multitude of sectors, including life sciences, agrigenomics, and pharmaceuticals. The company's products are pivotal in advancing personalised medicine, genetic disease research, cancer diagnostics, and agricultural biology. They also play a critical role in academic research and are instrumental in large-scale projects such as genome-wide association studies (GWAS) and various national genomics initiatives. #### Reputation and Notable Technologies Within the scientific community, Illumina is highly regarded for its innovative contributions to genomics. The company's patented sequencing-by-synthesis (SBS) technology has set industry standards for data quality and throughput. Its MiSeq and HiSeq systems were groundbreaking, significantly lowering the cost of sequencing and democratising genomics research. Illumina continues to lead the market with its comprehensive ecosystem of sequencing solutions, maintaining a dominant position in the NGS space. #### Conclusion In summary, Illumina has cemented its status as a cornerstone in the genomics industry, enabling advancements in science and medicine through its cutting-edge technologies. Its commitment to innovation and quality continues to empower researchers and clinicians to explore the complexities of the genome and transform the future of healthcare.

NovaSeq 6000

NextSeq 500

HiSeq 2000

MiSeq

Genome Analyzer IIx

Products: 144

Pages: 5

Sort By

Trusted Supplier